Business
– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA;...
Hi, what are you looking for?
– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA;...
– Jeremy Levin – / By David Frank / This week revealed the 2012 salary for the CEO of Teva Pharmaceuticals (NASDAQ: TEVA). Teva...